Alzheimer's Disease

Alzheimer's Disease currently costs the U.S. $18.3 million every hour of every day of every year.1 These staggering costs represent both the sheer scope of the problem — with aging Baby Boomers set to tip the number of sufferers exponentially — and the financial impact of each individual case — which puts long-term strain on families to provide care, housing and other assistance.

Currently, 93 medicines and diagnostics are in development to combat Alzheimer's.2 Because of the massive numbers involved, even a small breakthrough could have a significant effect.

If, by 2025, just one new treatment could be developed that delays the onset of Alzheimer’s by 5 years, it would save over $367 billion in healthcare costs annually by 2050. It would delay the onset of Alzheimer’s by 5 years, and the number of Alzheimer’s patients would drop by nearly one-half by 2050.3

This is one disease where the fight is truly just beginning. Today, 1 in 3 Americans die with Alzheimer's or another kind of dementia.4 To change those numbers, innovation needs to not only continue, but expand.

  1. https://www.alz.org/documents_custom/abam_national_release_060116.pdf
  2. http://www.phrma.org/research/medicines-development-alzheimers-disease
  3. https://www.alz.org/documents_custom/trajectory.pdf
  4. http://www.alz.org/facts/